Incyte and AstraZeneca to Enter Clinical Trial Collaboration in Early Lung Cancer
Go back to Incyte and AstraZeneca to Enter Clinical Trial Collaboration in Early Lung Cancer| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 5,146,218 | |||||
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.40 -2.35 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.75 | 52 Week High | $118.49 | |||
| Open | $124.11 | 52 Week Low | $55.00 | |||
| Day High | $126.40 | P/E | N/A | |||
| Day Low | $122.22 | EPS | $-0.56 | |||
| Volume | 1,283,253 | |||||
